Asia Pacific Personalized Medicine Biomarkers Market Size & Outlook
Asia Pacific personalized medicine biomarkers market, 2018-2030 (US$M)
Related Markets
Asia Pacific personalized medicine biomarkers market highlights
- The Asia Pacific personalized medicine biomarkers market generated a revenue of USD 2,468.6 million in 2021.
- The market is expected to grow at a CAGR of 17.3% from 2022 to 2030.
- In terms of segment, treatment selection was the largest revenue generating application in 2021.
- Early Detection/Screening is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2022 to 2030.
Asia Pacific data book summary
| Market revenue in 2021 | USD 2,468.6 million |
| Market revenue in 2030 | USD 10,392.3 million |
| Growth rate | 17.3% (CAGR from 2021 to 2030) |
| Largest segment | Treatment selection |
| Fastest growing segment | Early Detection/Screening |
| Historical data covered | 2018 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Early Detection/Screening, Diagnosis, Treatment Selection, Monitoring |
| Key market players worldwide | Labcorp Holdings Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Genome Medical, Coriell Life Sciences, Thermo Fisher Scientific Inc, NeoGenomics, Foundation Medicine, Illumina Inc, Guardant Health Inc |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 21.0% of the global personalized medicine biomarkers market in 2021.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 10,392.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Personalized Medicine Biomarkers Market Scope
Personalized Medicine Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific personalized medicine biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to personalized medicine biomarkers market will help companies and investors design strategic landscapes.
Treatment selection was the largest segment with a revenue share of 52.87% in 2024. Horizon Databook has segmented the Asia Pacific personalized medicine biomarkers market based on early detection/screening, diagnosis, treatment selection, monitoring covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Asia Pacific personalized medicine biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific personalized medicine biomarkers market databook
-
Our clientele includes a mix of personalized medicine biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific personalized medicine biomarkers market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific personalized medicine biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific personalized medicine biomarkers market report size, by country, 2018-2030 (US$M)
Asia Pacific Personalized Medicine Biomarkers Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
